Desensitization with daratumumab in a pediatric patient with thalassemia major and high donor-specific antibody prior to haploidentical transplantation Research Letter

  

Authors:	Suwantarat, N.; Iamsirirak, P.; Chanapai, J.; Pakakasama, S.; Andersson, B. S.; Boelens, J. J.; Anurathapan, U.; Hongeng, S.
Title:	Desensitization with daratumumab in a pediatric patient with thalassemia major and high donor-specific antibody prior to haploidentical transplantation
Keywords:	child; clinical article; school child; busulfan; fludarabine; case report; hepatitis; rituximab; letter; bortezomib; multiple myeloma; cyclophosphamide; dexamethasone; plasmapheresis; hematopoietic stem cell transplantation; monoclonal antibody; chimera; antibodies, monoclonal; acute graft versus host disease; donor; tissue donors; beta thalassemia; graft versus host reaction; beta-thalassemia; autoimmune hemolytic anemia; drug therapy; peripheral blood stem cell transplantation; therapy; sirolimus; thymocyte antibody; hla system; steroid therapy; thalassemia major; blood donor; procedures; desensitization; mycophenolic acid; pure red cell anemia; fluorescence intensity; humans; human; male; female; evans syndrome; haploidentical transplantation; daratumumab; pediatric patient; haploidentical donor; desensitization, immunologic; transplantation, haploidentical
Journal Title:	Pediatric Blood and Cancer
Volume:	71
Issue:	11
ISSN:	1545-5009
Publisher:	Wiley Periodicals, Inc
Date Published:	2024-11-01
Start Page:	e31311
Language:	English
DOI:	10.1002/pbc.31311
PUBMED:	39228048
PROVIDER:	scopus
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85203011195&doi=10.1002%2fpbc.31311&partnerID=40&md5=d201445a84bd81d3c23e661cef98fba0
Notes:	Letter -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/220062